| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT07533708 A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours |
Recruitment opened |
| 2026-08-12 | NCT07533708 A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours |
Trial sites expanded: 0 -> 5 locations |
| 2026-07-25 | NCT07518043 A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors |
Recruitment opened |
| 2026-07-25 | NCT07518043 A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors |
Trial sites expanded: 0 -> 7 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06532006 | A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for… | Gastroesophageal-junction Cancer | Recruiting |
| NCT04301739 | to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo… | Triple Negative Breast Cancer | Not Yet Recruiting |
| NCT06841185 | A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of… | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |
| NCT06847334 | A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of… | Non-Squamous Non-Small Cell Lung Cancer | Not Yet Recruiting |
| NCT06895512 | A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination… | Newly Diagnosed Multiple Myeloma | Not Yet Recruiting |
| NCT05346224 | A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant… | Breast Cancer | Active, Not Recruiting |
| NCT05468489 | To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in… | Extensive Stage Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05353257 | A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With… | Limited-Stage Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT04547166 | A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With… | Metastatic Colorectal Cancer | Recruiting |
| NCT07294508 | A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive… | HER2 + Breast Cancer | Recruiting |
| NCT07459751 | A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43… | Advanced or Metastatic Squamous Non-Small Cell Lung Cancer | Recruiting |
| NCT07294534 | A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination… | HER2 + Breast Cancer | Not Yet Recruiting |
| NCT07318883 | A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and… | Squamous NSCLC | Not Yet Recruiting |
| Phase 2 | |||
| NCT06349980 | A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and… | Carcinoma, Hepatocellular | Recruiting |
| NCT06742892 | A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or… | Carcinoma, Hepatocellular | Recruiting |
| NCT06832202 | A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone… | HER2-low Hormone Receptor Positive Breast Cancer | Recruiting |
| NCT06907615 | A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung… | Non Small Cell Lung Cancer | Recruiting |
| NCT07106892 | Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an… | Colorectal Cancer (CRC) | Recruiting |
| NCT07038382 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion… | Membranous Nephropathy | Recruiting |
| NCT07115485 | Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an… | Gastric or Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT06839066 | A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal… | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT06857279 | A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head… | Carcinoma of Head and/or Neck | Recruiting |
| NCT06769152 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC)… | Cervical Cancer | Recruiting |
| NCT06769113 | A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC… | Esophageal Cancer | Recruiting |
| NCT07269782 | A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as… | Non Small Cell Lung Cancer | Recruiting |